文献速递肝病

新冠疫情期间与疫情前相比肝硬化患者院内感染减少:口罩与限制探视的影响

Reduction in Nosocomial Infections in Patients With Cirrhosis During the COVID-19 Era Compared with Pre-COVID-19: Impact of Masking and Restricting Visitation.
PubMed 文献 · Am J Gastroenterol · 2022-07-21

研究纳入2019年3月至2020年2月(新冠前,n=234)和2020年3月至2021年3月(新冠时代,n=296)两个ICU肝硬化患者队列,发现新冠时代患者尽管入院MELD-Na、qSOFA和WBC计数更高且ICU住院时间更长,院内感染发生率更低(3% vs 10%,P<0.001),肝移植率更高。

要点

  • 新冠时代ICU肝硬化患者院内感染发生率3%,低于新冠前的10%(P<0.001)。
  • 新冠时代患者入院MELD-Na、qSOFA和WBC计数更高且ICU住院时间更长。
  • 新冠时代限制措施可能减少危重肝硬化患者的院内感染。

核心结论

  • 新冠时代的限制措施可能减少危重肝硬化患者的院内感染。

研究设计与样本

  • 纳入2019年3月至2020年2月(新冠前,n=234)和2020年3月至2021年3月(新冠时代,n=296)两个ICU肝硬化患者队列。

主要发现

  • 新冠时代患者院内感染发生率3% vs 新冠前10%,P<0.001。
  • 新冠时代患者入院MELD-Na、qSOFA和WBC计数更高且ICU住院时间更长。
  • 新冠时代患者肝移植率高于新冠前患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Nosocomial infections (NIs) in critically ill patients with cirrhosis result in higher death and transplant delisting. NIs are promoted by staff, visitors, and the environment, all of which were altered to reduce pathogen transmission after COVID-19. Two cohorts of intensive care unit patients with cirrhosis from March 2019 to February 2020 (pre-COVID, n = 234) and March 2020 to March 2021 (COVID era, n = 296) were included. We found that despite a higher admission MELD-Na, qSOFA, and WBC count and requiring a longer intensive care unit stay, COVID-era patients developed lower NIs (3% vs 10%, P < 0.001) and had higher liver transplant rates vs pre-COVID patients. COVID-era restrictions could reduce NIs in critically ill patients with cirrhosis.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Park D, Houston K, Duong NK, et al. Reduction in Nosocomial Infections in Patients With Cirrhosis During the COVID-19 Era Compared with Pre-COVID-19: Impact of Masking and Restricting Visitation. Am J Gastroenterol. 2022. PMID: 35862828. doi:10.14309/ajg.0000000000001911

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。